Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia® (ferric citrate)
November 09, 2016 10:41 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate Update
November 09, 2016 07:01 ET
|
Keryx Biopharmaceuticals, Inc.
The company has established adequate supply of Auryxia® (ferric citrate) and is prepared to make this medicine available to people on dialysis pending U.S. FDA approval of second contract...
Keryx Biopharmaceuticals to Webcast its Presentation at Stifel’s 2016 Healthcare Conference on November 15
November 03, 2016 08:31 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2016 Financial Results on Wednesday, November 9, 2016
November 01, 2016 09:15 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Nov. 01, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to market for people with renal...
Keryx Biopharmaceuticals Announces Presentations of Data at the American Society of Nephrology Kidney Week 2016 Annual Meeting
October 14, 2016 10:12 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals to Webcast its Presentation at Ladenburg Thalmann’s 2016 Healthcare Conference
September 21, 2016 08:30 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals to Present at Two Upcoming Investor Healthcare Conferences
September 01, 2016 08:30 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals Announces Interruption in Supply of Auryxia® (ferric citrate) and Second Quarter 2016 Financial Results
August 01, 2016 07:30 ET
|
Keryx Biopharmaceuticals, Inc.
- Supply interruption does not affect the safety profile of currently available Auryxia -- Company withdraws its 2016 financial guidance -- Company to host conference call today at 8:30 a.m. EDT - ...
Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2016 Financial Results on Monday, August 1, 2016
July 29, 2016 08:30 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, July 29, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy
June 27, 2016 08:00 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, June 27, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...